MRI-guided HIFU-mediated heating and lesion formation enhanced with phase-shift n
MRI 引导的 HIFU 介导的加热和病变形成通过相移增强
基本信息
- 批准号:8100353
- 负责人:
- 金额:$ 19.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcousticsAdverse effectsAwardBlood CirculationCancer PatientCause of DeathCell NucleusCoagulation ProcessDepositionDimensionsDoseEffectivenessEnhancing LesionEnsureEvolutionFocused Ultrasound TherapyFundingHeatingHourIn VitroLesionLocalized Malignant NeoplasmLocationMagnetic Resonance ImagingMalignant NeoplasmsMediatingMethodsModelingMonitorOryctolagus cuniculusPatient CarePhasePhysiologic pulseProtocols documentationResearchSeriesSolid NeoplasmSpatial DistributionTechnologyThermal Ablation TherapyThermometryTimeTissuesUltrasonic TransducerUltrasonographyUnited Statescancer therapycostdensitydesignimprovedin vivonanoemulsionnew technologypublic health relevancetumorvaporvaporization
项目摘要
DESCRIPTION (provided by applicant): MRI-guided HIFU-mediated heating and lesion formation enhanced with phase-shift nanoemulsions MRI-guided high intensity focused ultrasound (HIFU) has shown promise as a method for destroying solid tumors noninvasively through thermal mechanisms. While HIFU can destroy localized malignancies via the formation of lesions (i.e. coagulated tissue) with a high degree of spatial precision, it can take hours to treat an entire tumor. This has limited the efficiency of MRI-guided HIFU cancer therapy, and has hindered its acceptance clinically. It has been demonstrated that acoustic cavitation (i.e. acoustically-driven bubbles) can increase the efficiency of MRI-guided HIFU mediated heating and lesion formation in tissue. We have developed a phase-shift nanoemulsion (PSNE) to serve as nuclei for acoustic cavitation. By accumulating preferentially in solid tumors, the PSNE localize bubble nuclei to the diseased tissue. The PSNE can be vaporized acoustically, and the resultant bubbles can be used to accelerate ultrasound-mediated heating, thus reducing the time required for treatment of bulk tumors. We have designed a series of studies to evaluate the effectiveness of the strategy for localizing bubble-enhanced heating and producing predictable lesions in solid tumors. Finally, MR imaging and thermometry can be used to monitor bubble-enhanced HIFU-mediated heating, ensure that the required thermal dose for thermal ablation is delivered, and predict the lesion volume and location.
PUBLIC HEALTH RELEVANCE: Cancer is the second leading cause of death in the United States. The research outlined in this proposal will develop technology and protocols for localized treatment of solid tumors using focused ultrasound with negligible adverse side effects. Ultimately, this technology has the potential to reduce the time and number of treatments required for tumor regression, thus reducing costs and improving cancer patient care.
描述(由申请人提供):通过相移纳米乳剂增强 MRI 引导的 HIFU 介导的加热和病变形成 MRI 引导的高强度聚焦超声(HIFU)已显示出作为一种通过热机制非侵入性破坏实体瘤的方法的前景。虽然 HIFU 可以通过形成高度空间精度的病灶(即凝固组织)来破坏局部恶性肿瘤,但治疗整个肿瘤可能需要数小时。这限制了MRI引导的HIFU癌症治疗的效率,并阻碍了其在临床上的接受。已经证明,声空化(即声驱动的气泡)可以提高 MRI 引导的 HIFU 介导的组织加热和病变形成的效率。我们开发了一种相移纳米乳液(PSNE)作为声空化的核。通过优先在实体瘤中积累,PSNE 将气泡核定位于患病组织。 PSNE 可以声波汽化,产生的气泡可用于加速超声介导的加热,从而减少治疗大块肿瘤所需的时间。我们设计了一系列研究来评估局部气泡增强加热和在实体瘤中产生可预测病变的策略的有效性。最后,MR 成像和测温可用于监测气泡增强 HIFU 介导的加热,确保提供热消融所需的热剂量,并预测病变体积和位置。
公共卫生相关性:癌症是美国第二大死因。该提案中概述的研究将开发使用聚焦超声局部治疗实体瘤的技术和方案,且副作用可忽略不计。最终,这项技术有可能减少肿瘤消退所需的时间和治疗次数,从而降低成本并改善癌症患者的护理。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The impact of vaporized nanoemulsions on ultrasound-mediated ablation.
- DOI:10.1186/2050-5736-1-2
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Zhang P;Kopechek JA;Porter TM
- 通讯作者:Porter TM
Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions.
- DOI:10.1088/0031-9155/59/13/3465
- 发表时间:2014-07-07
- 期刊:
- 影响因子:3.5
- 作者:Kopechek JA;Park EJ;Zhang YZ;Vykhodtseva NI;McDannold NJ;Porter TM
- 通讯作者:Porter TM
Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo.
- DOI:10.1260/2040-2295.4.1.109
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Kopechek JA;Park E;Mei CS;McDannold NJ;Porter TM
- 通讯作者:Porter TM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tyrone Porter其他文献
Tyrone Porter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tyrone Porter', 18)}}的其他基金
Focal ultrasound-mediated nonthermal ablation of brain tumors
局灶超声介导的脑肿瘤非热消融
- 批准号:
10346714 - 财政年份:2019
- 资助金额:
$ 19.12万 - 项目类别:
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation
通过相移纳米仿真增强超声介导的肿瘤消融
- 批准号:
8529144 - 财政年份:2013
- 资助金额:
$ 19.12万 - 项目类别:
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation
通过相移纳米仿真增强超声介导的肿瘤消融
- 批准号:
8656622 - 财政年份:2013
- 资助金额:
$ 19.12万 - 项目类别:
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation
通过相移纳米仿真增强超声介导的肿瘤消融
- 批准号:
9061682 - 财政年份:2013
- 资助金额:
$ 19.12万 - 项目类别:
Neutral pressure-sensitive nanoemulsion for localized siRNA delivery
用于局部 siRNA 递送的中性压敏纳米乳液
- 批准号:
8386276 - 财政年份:2012
- 资助金额:
$ 19.12万 - 项目类别:
Neutral pressure-sensitive nanoemulsion for localized siRNA delivery
用于局部 siRNA 递送的中性压敏纳米乳液
- 批准号:
8510645 - 财政年份:2012
- 资助金额:
$ 19.12万 - 项目类别:
MRI-guided HIFU-mediated heating and lesion formation enhanced with phase-shift n
MRI 引导的 HIFU 介导的加热和病变形成通过相移增强
- 批准号:
7991271 - 财政年份:2010
- 资助金额:
$ 19.12万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 19.12万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 19.12万 - 项目类别:
Studentship














{{item.name}}会员




